help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mersebach, H.
Right arrow Articles by Feldt-Rasmussen, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mersebach, H.
Right arrow Articles by Feldt-Rasmussen, U.
The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 12 5689-5695
Copyright © 2003 by The Endocrine Society

Abnormal Sympathoadrenal Activity, but Normal Energy Expenditure in Hypopituitarism

Henriette Mersebach, Ole Lander Svendsen, Arne Astrup and Ulla Feldt-Rasmussen

Department of Endocrinology (H.M., O.L.S., U.F.-R.), Copenhagen University Hospital, DK-2100 Copenhagen, Denmark; and The Research Department of Human Nutrition (A.A.), The Royal Veterinary and Agricultural University, DK-1958 Frederiksberg, Denmark

Address all correspondence and requests for reprints to: Henriette Mersebach, M.D., Department of Endocrinology, PE 2131, Copenhagen University Hospital, 9 Blegdamsvej, DK-2100 Copenhagen Ø, Denmark. E-mail: mersebach{at}rh.dk.

In this study of 23 hypopituitary patients and 26 healthy controls, we have addressed whether the obese state of substituted hypopituitary patients is facilitated by abnormal sympathoadrenal activity or energy expenditure (EE). All patients received adequate substitution therapy including GH therapy. The investigation program included assessment of sympathoadrenal activity (urinary catecholamines), body composition (dual-energy x-ray absorptiometry), appetite sensations (visual analog scale), and EE (indirect calorimetry in respiration chamber). Twenty-four-hour urinary epinephrine adjusted for lean body mass and fat mass was significantly lower in patients compared with controls. GH and hydrocortisone were single negative predictors of urinary epinephrine. The major determinants of EE in patients were lean body mass and fat mass, explaining 96, 95, and 80% of the variance in 24-h EE, sleeping EE, and basal metabolic rate, respectively. Addition of urinary catecholamines explained another 1–4% of the variance in 24-h EE and basal metabolic rate, respectively. Lean patients exhibited significantly more hunger than obese patients and lean controls. In conclusion, hypopituitary patients have lower sympathoadrenal activity but normal EE, compared with healthy controls. This may reflect a central defect in hypopituitarism, however the possible impact of long-term GH and hydrocortisone treatment requires further attention.

This study was supported by Pharmacia, Denmark. H.M. was supported by Copenhagen University Hospital.

Abbreviations: BMC, Bone mineral content; BMI, body mass index; BMR, basal metabolic rate; DE, duration of exercise; DEXA, dual-energy x-ray absorptiometry; EE, energy expenditure; FFM, fat-free mass; FM, fat mass; GHD, GH deficiency; HR, heart rate; LBM, lean body mass; PAL, physical activity level; RQ, respiratory quotient; SEE, sleeping EE; SNS, sympathetic nervous system; SPA, spontaneous physical activity; VAS, visual analog scale.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society